Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
(2019)
Journal Article
Hickman, M., Dillon, J. F., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., Donnan, P., Eriksen, A., Flowers, P., Goldberg, D., Hollingworth, W., Ijaz, S., Liddell, D., Mandal, S., Martin, N., Beer, L. J. Z., Drysdale, K., Fraser, H., Glass, R., Graham, L., …Hutchinson, S. J. (2019). Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol). BMJ Open, 9(9), Article e029538. https://doi.org/10.1136/bmjopen-2019-029538
Hepatitis C virus (HCV) is the second largest contributor to liver disease in the UK, with injecting drug use as the main risk factor among the estimated 200 000 people currently infected. Despite effective prevention interventions, chronic HCV preva...
Read More about Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol).